TrialBritish journal of cancer2024

Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.

Sophie Postel-Vinay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.